🔆 Beacon

← Search all trials on Beacon

Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer

Recruiting now Phase 2 NCT05849129

Run by The Canadian College of Naturopathic Medicine · for 18 and older · All sexes

What this study is about

This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan to enroll 90 patients over 5 years.

Who can join (things the study team will check)

✅ You may be able to join if…

🚫 You may not be able to join if…

Where this trial is running

Who to contact

Dugald Seely, ND, MSc · 613-792-1222 · dseely@thechi.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05849129.

Open the interactive checklist for this trial →

Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.

Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.